Young Teresa L. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$40,535.24

Insider Activity of Young Teresa L.

According to the SEC Form 4 filings, Young Teresa L., being in a position of

  1. See Remarks at Seres Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1117 shares for $18,662,
    over all time since 2023-10-30, has bought 0 shares, and sold 40487 shares for $60,638.

Biography of Young Teresa L.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $18,6622100

Comparison of Insiders on Amount of Buys and Sells

2026-02-15SaleSeres Therapeutics, Inc.
MCRB
See Remarks
75
0.0008%
$8.47$635-20.29%
2025-11-15SaleSeres Therapeutics, Inc.
MCRB
See Remarks
1,042
0.0123%
$17.30$18,027-64.28%
2025-08-18SaleSeres Therapeutics, Inc.
MCRB
See Remarks
59
0.0006%
$16.65$982-47.31%
2025-05-16SaleSeres Therapeutics, Inc.
MCRB
See Remarks
63
0.0007%
$7.28$459+91.62%
2025-02-18SaleSeres Therapeutics, Inc.
MCRB
See Remarks
3,338
0.0019%
$0.81$2,704-10.35%
2024-11-18SaleSeres Therapeutics, Inc.
MCRB
See Remarks
735
0.0004%
$0.54$398+32.3%
2024-10-28SaleSeres Therapeutics, Inc.
MCRB
See Remarks
2,983
0.0015%
$0.69$2,059+9.25%
2024-08-16SaleSeres Therapeutics, Inc.
MCRB
See Remarks
728
0.0004%
$0.84$612-14.77%
2024-08-05SaleSeres Therapeutics, Inc.
MCRB
See Remarks
24,480
0.0137%
$1.08$26,534-40.76%
2024-05-15SaleSeres Therapeutics, Inc.
MCRB
See Remarks
703
0.0005%
$0.94$661-14.74%
2024-02-16SaleSeres Therapeutics, Inc.
MCRB
See Remarks
3,374
0.0027%
$1.08$3,644-19.19%
2023-10-30SaleSeres Therapeutics, Inc.
MCRB
See Remarks
2,907
0.0021%
$1.35$3,924-31.83%
Total: 12
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.